As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual- or tri-receptor agonists (incretin mimetics) redefine metabolic health management, oncology clinicians increasingly face questions about their use during and after active cancer treatment
In short, GLP-1 receptor agonists now occupy a leading position among the worlds best-selling medicines , reflecting unprecedented demand for these new diabetes and obesity treatments
improves with slower dose escalation Vomiting, diarrhea, or constipation Bloating, heartburn, or stomach discomfort Reduced appetite and early fullness Fatigue or headache Less common side effects Injection-site reactions Fatigue or changes in taste Temporary mild hair thinning (limited evidence) Serious but rare risks Pancreatitis seek care immediately if you experience severe abdominal pain Gallbladder disease or gallstones Kidney complications, particularly from dehydration Thyroid C-cell tumor risk in patients with medullary thyroid cancer history or MEN2 Low blood sugar when combined with insulin or sulfonylureas Contact your provider immediately if you experience severe or persistent abdominal pain, constant vomiting, signs of dehydration, yellowing of the skin or eyes, or symptoms of low blood sugar
As you know, Ozempic 1 mg helps your body regulate food, sugar, and fat metabolism, but other health benefits were also discovered during the drug trials
Managing Breakthrough Hunger and the End-of-Week Slump Semaglutide has a half-life of about seven days
Final Verdict: Is Join Polly Worth It